Eisai
4523.T
#2152
Rank
NZ$16.03 B
Marketcap
NZ$56.82
Share price
3.73%
Change (1 day)
11.99%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$16.28 Billion

According to Eisai's latest financial reports the company's total assets are NZ$16.28 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Eisai - Total assets on balance sheet (from 2009 to 2024)

Total assets by year

Year Total assets Change
2023-03-31NZ$15.14 B3.39%
2022-03-31NZ$14.64 B3.67%
2021-03-31NZ$14.12 B-14.47%
2020-03-31NZ$16.51 B16.77%
2019-03-31NZ$14.14 B3.74%
2018-03-31NZ$13.63 B3.71%
2017-03-31NZ$13.14 B4.98%
2016-03-31NZ$12.52 B6.2%
2015-03-31NZ$11.79 B8.12%
2014-03-31NZ$10.90 B-13%
2013-03-31NZ$12.53 B-15.1%
2012-03-31NZ$14.76 B-10.72%
2011-03-31NZ$16.54 B-0.64%
2010-03-31NZ$16.64 B-18.64%
2009-03-31NZ$20.46 B46.14%
2008-03-31NZ$14.00 B48.94%
2007-03-31NZ$9.40 B-10.34%
2006-03-31NZ$10.48 B20.58%
2005-03-31NZ$8.69 B-1.78%
2004-03-31NZ$8.85 B-2.25%
2003-03-31NZ$9.05 B-4.59%
2002-03-31NZ$9.49 B-13.13%
2001-03-31NZ$10.92 B